Cardiac resynchronization therapy: left or left-and-right for optimal symptomatic effect the LOLA ROSE study | Zendy

Alexander Sirker | Zendy; MO Thomas | Zendy; S R Baker | Zendy; Julia A Shrimpton | Zendy; Scott D. Jewell | Zendy; L. Lee | Zendy; R Rankin | Zendy; V. Griffiths | Zendy; N. Cooter | Zendy; R. James | Zendy; S. O'Nunain | Zendy; D Hildick-Smith | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cardiac resynchronization therapy: left or left-and-right for optimal symptomatic effect the LOLA ROSE study

Author(s) -

Alexander Sirker,

MO Thomas,

S R Baker,

Julia A Shrimpton,

Scott D. Jewell,

L. Lee,

R Rankin,

V. Griffiths,

N. Cooter,

R. James,

S. O'Nunain,

D Hildick-Smith

Publication year - 2007

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/eum161

Subject(s) - medicine , cardiac resynchronization therapy , heart failure , cardiology , ejection fraction

Biventricular (BiV) pacing and left univentricular (LUV) pacing can each produce clinical benefits in heart failure. The impact of modern refinements in pacing optimization on the relative benefits of these two modes is unknown. We aimed to compare these two modes in patients with heart failure, using Echo-based optimization of each pacing mode.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research